Cargando…
Novel Delivery Systems for Checkpoint Inhibitors
Checkpoint inhibition (CPI) therapies have been proven to be powerful clinical tools in treating cancers. FDA approvals and ongoing clinical development of checkpoint inhibitors for treatment of various cancers highlight the immense potential of checkpoint inhibitors as anti-cancer therapeutics. The...
Autores principales: | Lamichhane, Purushottam, Deshmukh, Rahul, Brown, Julie A., Jakubski, Silvia, Parajuli, Priyanka, Nolan, Todd, Raja, Dewan, Badawy, Mary, Yoon, Thomas, Zmiyiwsky, Mark, Lamichhane, Narottam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789831/ https://www.ncbi.nlm.nih.gov/pubmed/31373327 http://dx.doi.org/10.3390/medicines6030074 |
Ejemplares similares
-
Immunotherapies and Combination Strategies for Immuno-Oncology
por: Barbari, Cody, et al.
Publicado: (2020) -
Checkpoint Inhibition: Will Combination with Radiotherapy and Nanoparticle-Mediated Delivery Improve Efficacy?
por: Lamichhane, Purushottam, et al.
Publicado: (2018) -
Resistance to Checkpoint Inhibition in Cancer Immunotherapy
por: Barrueto, Luisa, et al.
Publicado: (2020) -
Colorectal Cancer and Probiotics: Are Bugs Really Drugs? †
por: Lamichhane, Purushottam, et al.
Publicado: (2020) -
[(18)F]-Fluorinated Carboplatin and [(111)In]-Liposome for Image-Guided Drug Delivery
por: Lamichhane, Narottam, et al.
Publicado: (2017)